Article Details

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Retrieved on: 2020-12-11 19:18:45

Tags for this article:

Click the tags to see associated articles and topics

Inclisiran Approved in Europe for Lowering LDL Cholesterol. View article details on hiswai:

Excerpt

While alirocumab and evolocumab are <b>monoclonal antibodies</b> that inhibit circulating PCSK9, inclisiran is an siRNA that halts the hepatic production of ...

Article found on: www.tctmd.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo